Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal

<p>Abstract</p> <p>Background</p> <p>Despite worldwide recognition of the burden of dementia, no epidemiological data is yet available in Portugal. The objective of this study is to estimate the prevalence and describe the pattern of cognitive impairment with dementia or no dementia (CIND) in rural and urban populations from Northern Portugal.</p> <p>Methods</p> <p>Two random samples of residents aged 55 to 79 years in rural and urban communities were drawn from the health centres registries to be screened for cognitive impairment. The screening criteria for dementia were an abnormal Mini-Mental State Examination (MMSE) score or a Blessed Dementia Scale score. After excluding those who tested positive for dementia, cut-off points for CIND were set at 1 standard deviation below the mean of the MMSE according to educational level. All those who screened positive either for dementia or CIND were examined by a neurologist for establishing a definitive diagnosis.</p> <p>Results</p> <p>The prevalence of cognitive impairment was higher in rural than in urban populations, 16.8% (95% CI: 14.3-19.8%) vs. 12.0% (95%CI: 9.3-15.4%), with a rural/urban prevalence ratio (PR) of 2.16 (95% CI: 1.04-4.50) in the eldest and 2.19 (95% CI: 1.01-4.76) in persons with vascular risk factors. The prevalence of dementia was 2.7% (95% CI: 1.9-3.8%) with a rural/urban PR = 2.1 and the prevalence of CIND was 12.3% (95% CI: 10.4-14.4%) and PR = 1.3. The prevalence of dementia increases exponentially with age and in those with cerebrovascular disease or other comorbid conditions while the prevalence of CIND, besides these factors, is also higher in persons with low levels of education or vascular risk factors. Alzheimer's and vascular disease were equally likely aetiologies of dementia (38.7%), the later more common in men PR(F:M = 0.3) as opposed to the former PR(F:M = 2.0). Vascular CIND, associated either with cerebrovascular disease or vascular risk factors was more frequent (39.7%) then depression (18.4%) or any other aetiology.</p> <p>Conclusions</p> <p>The prevalence of cognitive impairment is higher in rural compared with urban populations. This is shown in the synergy between age and rurality, with the rural/urban prevalence ratio increasing with age. In this relatively young population from Northern Portugal, cerebrovascular disease as well as vascular risk factors account for 48% of overall cognitive impairment.</p

Dark sectors 2016 Workshop: community report

This report, based on the Dark Sectors workshop at SLAC in April 2016, summarizes the scientific importance of searches for dark sector dark matter and forces at masses beneath the weak-scale, the status of this broad international field, the important milestones motivating future exploration, and promising experimental opportunities to reach these milestones over the next 5-10 years

Exploring different pretreatment methodologies for allowing microalgae growth in undiluted piggery wastewater

The overapplication of manure on agricultural soils leads to nitrogen and phosphorus discharge into the aquatic environment, resulting in serious eutrophication problems and decreased water quality. Piggery wastewater (PWW) can be treated by microalgae to recycle nutrients, but the toxic levels of ammonia and organic matter hinder their growth. Fresh water is usually used to dilute PWW, but it is a scarce resource. The implementation of a pretreatment step before microalgae-based treatment could make PWW suitable for microalgae growth. Electrocoagulation, ammonia stripping, photo-Fenton, and constructed wetlands were evaluated as pretreatment methods to reduce ammonia, chemical oxygen demand (COD), color, and total suspended solids. Moreover, the pretreated PWWs were tested to grow the microalga Tetradesmus obliquus. Photo-Fenton showed the best results among the other pretreatments, achieving removal efficiencies above 90%, except for ammonia. This resulted in T. obliquus being capable of growing on undiluted PWW, even at higher ammonia levels, achieving similar biomass productivity to synthetic medium (66.4 ± 17.8 mg·L−1·day−1 and 60.1 ± 10.4 mg·L−1·day−1, respectively) almost doubling with pH control (116.5 mg·L−1·day−1). Thus, this pretreatment seems to be the most promising one to incorporate into microalgae-based treatment systems and must be further explored.info:eu-repo/semantics/publishedVersio

A Temporal Logic Based Theory of Test Coverage and Generation

This paper presents a theory of test coverage and generation from specifications written in extended finite state machines (EFSMs). We investigate a family of coverage criteria based on the information of control flow and data flow in EFSMs and characterize them using the temporal logic CTL. We discuss the complexity of minimal cost test generation and describe a simple heuristic which uses the capability of model checkers to construct counterexamples. Our approach extends the range of applications of model checking from automatic verification of finite state systems to automatic test generation from finite state systems

Innovative approach in sustainable agriculture: Harnessing microalgae potential via subcritical water extraction

ABSTRACT: Microalgae can contribute to sustainable agriculture and wastewater treatment. This study investigated Tetradesmus obliquus, grown in piggery wastewater (To-PWW), as a biostimulant/biofertilizer compared to biomass grown in synthetic medium (To-B). Subcritical water extraction was tested for disruption/hydrolysis of wet biomass, at three temperatures (120, 170, and 220 °C) and two biomass loads (1:10 and 1:80 (g dry biomass/mL water)). Extracts were evaluated for germination, and root formation/expansion. Residues were quantified for nutrient composition to assess their biofertilizer potential and tested for their affinity to oil compounds for bioremediation. The best germination was achieved by To-B extracts at 170 °C (1:10: 148 % at 0.2 g/L, 1:80: 145 % at 0.5 g/L). Only To-PWW extracts at 0.2 g/L had a significant germination effect (120 °C: 120–123 % for both loads; 170 °C: 115 % for 1:80). To-PWW extract at 120 °C and 1:10 significantly affected cucumber and mung bean root formation (224 and 268 %, respectively). Most extracts significantly enhanced root expansion, with all To-B extracts at 1:10 showing the best results (139–181 %). The residues contained essential nutrients (NPK), indicating their biofertilizer potential, helping decrease synthetic fertilizers demands. To-B residues had high affinity to toluene and diesel but lower to used cooking and car oils. To-PWW showed very low affinity to all oil compounds. Finally, all residues were only able to form stable emulsions with the used car oil. This study fully exploits the use of microalgal biomass in sustainable agriculture, producing biostimulant extracts, and residues for biofertilizer and bioremediation, from a low-cost wastewater source.info:eu-repo/semantics/publishedVersio

Physical Activity and Nutrition INfluences in Ageing: Current Findings from the PANINI Project

Background: The ageing of the population is a global challenge and the period of life spent in good health, although increasing, is not keeping pace with lifespan. Consequently, understanding the important factors that contribute to healthy ageing and validating interventions and influencing policy to promote healthy ageing are vital research priorities. Method: The PANINI project is a collaboration of 20 partners across Europe examining the influence of physical activity and nutrition in ageing. Methods utilised encompass the biological to the social, from genetics to the influence of social context. For example, epigenetic, immunological, and psychological assessments, and nutritional and sports science-based interventions have been used among older adults, as well as mathematical modelling and epidemiology. The projects are multi-disciplinary and examine health outcomes in ageing from a range of perspectives. Results: The results discussed here are those emerging thus far in PANINI from 11 distinct programmes of research within PANINI as well as projects cross-cutting the network. New approaches, and the latest results are discussed. Conclusions: The PANINI project has been addressing the impact of physical activity and nutrition on healthy ageing from diverse but interlinked perspectives. It emphasises the importance of using standardized measures and the advantages of combining data to compare biomarkers and interventions across different settings and typologies of older adults. As the projects conclude, the current results and final data will form part of a shared dataset, which will be made open access for other researchers into ageing processes.On behalf of the PANINI Consortiu

Efek Antidiabetes Yoghurt Pala Terhadap Penurunan Kadar Glukosa Darah Tikus Model Diabetes Melitus Tipe 2

Diabetes Melitus tipe 2 adalah penyakit gangguan metabolik yang di tandai oleh kenaikan gula darah akibat penurunan sekresi insulin oleh sel beta pankreas atau gangguan fungsi insulin (resistensi insulin). Potensi yoghurt dalam menurunkan kadar glukosa darah berhubungan dengan kemampuan bakteri asam laktat dalam yoghurt menurunkan kadar kolesterol dan plasma lipid, sehingga meningkatkan sensitivitas insulin pankreas. Buah pala mengandung senyawa kimia yang dapat menunjukkan sifat antioksidan dan antibakteri. Tujuan penelitian ini untuk mengetahui efek terapi yoghurt pala terhadap penurunan kadar glukosa darah tikus model diabetes melitus tipe 2. Penelitian ini menggunakan rancangan acak&nbsp;lengkap&nbsp;(RAL). Penelitian ini menggunakan rancangan acak lengkap (RAL) yang terdiri dari lima perlakuan dan tiga&nbsp;kali&nbsp;ulangan, yaitu K(-): Kelompok kontrol negatif yaitu kelompok tikus yang diberi STZ, K(+): Kelompok kontrol positif yaitu kelompok tikus yang diberi STZ 45 mg/ekor/hari kemudian diberikan obat glibenklamid&nbsp; selama 14 hari, 1.25: Kelompok tikus yang diberi STZ 45 mg /ekor/hari kemudian diberi ekstrak yoghurt pala&nbsp; 1.25 ml /ekor/hari selama 14 hari, 2.5: Kelompok tikus yang diberi STZ 45 mg /ekor/hari kemudian diberi ekstrak yoghurt pala&nbsp; 2.5 ml/ekor/hari selama 14 hari dan 5.0: Kelompok tikus yang diberi STZ 45 mg /ekor/hari kemudian diberi ekstrak yoghurt pala&nbsp; 5 ml/ekor/hari&nbsp;selama&nbsp;14&nbsp;hari. Hasil penelitian menunjukkan pemberian yoghurt pala terbukti memiliki efek antioksidan dalam menurunkan kadar glukosa darah dimana dosis yoghurt pala yang efektif adalah 5.0 ml

Bringing onco‐innovation to Europe’s healthcare systems. The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine

Rapid and continuing advances in biomarker testing are not being matched by uptake in health systems, and this is hampering both patient care and innovation. It also risks costing health systems the opportunity to make their services more efficient and, over time, more economical. The potential that genomics has brought to biomarker testing in diagnosis, prediction and research is being realised, pre‐eminently in many cancers, but also in an ever‐wider range of conditions— notably BRCA1/2 testing in ovarian, breast, pancreatic and prostate cancers. Nevertheless, the implementation of genetic testing in clinical routine setting is still challenging. Development is impeded by country‐related heterogeneity, data deficiencies, and lack of policy alignment on standards, approval—and the role of real‐world evidence in the process—and reimbursement. The acute nature of the problem is compellingly illustrated by the particular challenges facing the development and use of tumour agnostic therapies, where the gaps in preparedness for taking advantage of this innovative approach to cancer therapy are sharply exposed. Europe should already have in place a guarantee of universal access to a minimum suite of biomarker tests and should be planning for an optimum testing scenario with a wider range of biomarker tests integrated into a more sophisticated health system articulated around personalised medicine. Improving healthcare and winning advantages for Europe’s industrial competitiveness and innovation require an appropriate policy framework—starting with an update to outdated recommendations. We show herein the main issues and proposals that emerged during the previous advisory boards organised by the European Alliance for Personalized Medicine which mainly focus on possible scenarios of harmonisation of both oncogenetic testing and management of cancer patients

Bringing onco-innovation to Europe’s healthcare systems: the potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine

International audienceRapid and continuing advances in biomarker testing are not being matched by uptake in health systems, and this is hampering both patient care and innovation. It also risks costing health systems the opportunity to make their services more efficient and, over time, more economical. The potential that genomics has brought to biomarker testing in diagnosis, prediction and research is being realised, pre-eminently in many cancers, but also in an ever-wider range of conditions—notably BRCA1/2 testing in ovarian, breast, pancreatic and prostate cancers. Nevertheless, the implementation of genetic testing in clinical routine setting is still challenging. Development is impeded by country-related heterogeneity, data deficiencies, and lack of policy alignment on standards, approval—and the role of real-world evidence in the process—and reimbursement. The acute nature of the problem is compellingly illustrated by the particular challenges facing the development and use of tumour agnostic therapies, where the gaps in preparedness for taking advantage of this innovative approach to cancer therapy are sharply exposed. Europe should already have in place a guarantee of universal access to a minimum suite of biomarker tests and should be planning for an optimum testing scenario with a wider range of biomarker tests integrated into a more sophisticated health system articulated around personalised medicine. Improving healthcare and winning advantages for Europe’s industrial competitiveness and innovation require an appropriate policy framework—starting with an update to outdated recommendations. We show herein the main issues and proposals that emerged during the previous advisory boards organised by the European Alliance for Personalized Medicine which mainly focus on possible scenarios of harmonisation of both oncogenetic testing and management of cancer patients